These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18312406)

  • 1. A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3).
    Kieling C; Rieder CR; Silva AC; Saute JA; Cecchin CR; Monte TL; Jardim LB
    Eur J Neurol; 2008 Apr; 15(4):371-6. PubMed ID: 18312406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.
    Saute JA; Rieder CR; Castilhos RM; Monte TL; Schumacher-Schuh AF; Donis KC; D'Ávila R; Souza GN; Russo AD; Furtado GV; Gheno TC; Souza DO; Saraiva-Pereira ML; Portela LV; Camey S; Torman VB; Jardim LB
    J Neurol Sci; 2015 Nov; 358(1-2):72-6. PubMed ID: 26297649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinocerebellar ataxia type 3/Machado-Joseph disease starting before adolescence.
    Donis KC; Saute JA; Krum-Santos AC; Furtado GV; Mattos EP; Saraiva-Pereira ML; Torman VL; Jardim LB
    Neurogenetics; 2016 Apr; 17(2):107-13. PubMed ID: 26780339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Related factors of ICARS and SARA scores on spinocerebellar ataxia type 3/Machado-Joseph disease.
    Zhou J; Lei L; Liao X; Wang J; Jiang H; Tang B; Shen L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):498-503. PubMed ID: 21743140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2.
    Monte TL; Reckziegel ER; Augustin MC; Silva ASP; Locks-Coelho LD; Barsottini O; Pedroso JL; Vargas FR; Saraiva-Pereira ML; Leotti VB; Jardim LB;
    Cerebellum; 2017 Aug; 16(4):852-858. PubMed ID: 28456900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scale for the assessment and rating of ataxia: development of a new clinical scale.
    Schmitz-Hübsch T; du Montcel ST; Baliko L; Berciano J; Boesch S; Depondt C; Giunti P; Globas C; Infante J; Kang JS; Kremer B; Mariotti C; Melegh B; Pandolfo M; Rakowicz M; Ribai P; Rola R; Schöls L; Szymanski S; van de Warrenburg BP; Dürr A; Klockgether T; Fancellu R
    Neurology; 2006 Jun; 66(11):1717-20. PubMed ID: 16769946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3.
    da Silva Carvalho G; Saute JA; Haas CB; Torrez VR; Brochier AW; Souza GN; Furtado GV; Gheno T; Russo A; Monte TL; Schumacher-Schuh A; D'Avila R; Donis KC; Castilhos RM; Souza DO; Saraiva-Pereira ML; Torman VL; Camey S; Portela LV; Jardim LB
    Cerebellum; 2016 Aug; 15(4):518-25. PubMed ID: 26395908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of postural instability in spinocerebellar ataxia type 3 patients.
    Liu XH; Li Y; Xu HL; Sikandar A; Lin WH; Li GH; Li XF; Alimu A; Yu SB; Ye XH; Wang N; Ni J; Chen WJ; Gan SR
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1360-1370. PubMed ID: 32638517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease.
    Saute JA; de Castilhos RM; Monte TL; Schumacher-Schuh AF; Donis KC; D'Ávila R; Souza GN; Russo AD; Furtado GV; Gheno TC; de Souza DO; Portela LV; Saraiva-Pereira ML; Camey SA; Torman VB; de Mello Rieder CR; Jardim LB
    Mov Disord; 2014 Apr; 29(4):568-73. PubMed ID: 24399647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3/Machado-Joseph disease.
    Lei L; Liao Y; Liao W; Zhou J; Yuan Y; Wang J; Jiang H; Shen L; Tang B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):511-9. PubMed ID: 21743142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of ICARS in focal cerebellar lesions.
    Schoch B; Regel JP; Frings M; Gerwig M; Maschke M; Neuhäuser M; Timmann D
    Mov Disord; 2007 Nov; 22(15):2162-9. PubMed ID: 17712842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression rate of neurological deficits in a 10-year cohort of SCA3 patients.
    Jardim LB; Hauser L; Kieling C; Saute JA; Xavier R; Rieder CR; Monte TL; Camey S; Torman VB
    Cerebellum; 2010 Sep; 9(3):419-28. PubMed ID: 20467850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease.
    Matilla T; McCall A; Subramony SH; Zoghbi HY
    Ann Neurol; 1995 Jul; 38(1):68-72. PubMed ID: 7611728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Body Mass Index and Disease Severity in Chinese Spinocerebellar Ataxia Type 3 Patients.
    Yang JS; Chen PP; Lin MT; Qian MZ; Lin HX; Chen XP; Shang XJ; Wang DN; Chen YC; Jiang B; Chen YJ; Wang N; Chen WJ; Gan SR
    Cerebellum; 2018 Aug; 17(4):494-498. PubMed ID: 29476441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.
    Paulson HL
    Semin Neurol; 2007 Apr; 27(2):133-42. PubMed ID: 17390258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-ataxic Changes of Clinical Scales and Eye Movement in Machado-Joseph Disease: BIGPRO Study.
    de Oliveira CM; Leotti VB; Bolzan G; Cappelli AH; Rocha AG; Ecco G; Kersting N; Rieck M; Martins AC; Sena LS; Saraiva-Pereira ML; Jardim LB
    Mov Disord; 2021 Apr; 36(4):985-994. PubMed ID: 33438269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal neurophysiological study of SCA2 and SCA3 autosomal dominant hereditary spinocerebellar ataxias.
    Álvarez-Paradelo S; García A; Infante J; Berciano J
    Neurologia; 2011 Apr; 26(3):157-65. PubMed ID: 21163215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability and validity of the scale for the assessment and rating of ataxia: a study in 64 ataxia patients.
    Weyer A; Abele M; Schmitz-Hübsch T; Schoch B; Frings M; Timmann D; Klockgether T
    Mov Disord; 2007 Aug; 22(11):1633-7. PubMed ID: 17516493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.
    Dürr A; Stevanin G; Cancel G; Duyckaerts C; Abbas N; Didierjean O; Chneiweiss H; Benomar A; Lyon-Caen O; Julien J; Serdaru M; Penet C; Agid Y; Brice A
    Ann Neurol; 1996 Apr; 39(4):490-9. PubMed ID: 8619527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.